CLOV
$4.80+8.11%
Clover Health Investments Corp.Stock · HealthcareRussell 2000 · 0.07% of IWMNasdaq Composite · 0.006% of ONEQUS Stock Market · 0.003% of VTIRussell 3000 · 0.003% of IWV
CLOV financial statements
The full income statement, balance sheet, and cash-flow statement for Clover Health Investments Corp. (CLOV), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 495.2M2024-09 490.2M2024-12 494.6M2025-03 497.1M2025-06 509.0M2025-09 512.7M2025-12 517.3M2026-03 532.5M2026-06 531.2M+7.3% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
PeriodRangeOrderChangeFiguresAs-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 1.92B+40.3% | 1.37B+8.8% | 1.26B+15.0% | 1.10B-25.5% | 1.47B+118.8% | |
| Gross profit | — | — | 257M+266.3% | 70.2M+188.7% | -79.2M | |
| 2.01B+41.8% | 1.42B-3.3% | 1.47B+6.0% | 1.38B-34.4% | 2.11B+175.5% | ||
| Selling, general & administrative | 214M+21.4% | 176M-3.6% | 183M-10.1% | 204M+9.9% | 185M+53.3% | |
| General & administrative | 214M+21.4% | 176M-3.6% | 183M-10.1% | 204M+9.9% | 185M+53.3% | |
| Restructuring | — | 288K-97.1% | 9.82M | 0.00 | — | |
| Amortization of intangibles | — | — | — | 100K-85.7% | 700K | |
| Operating income | -85.5M-87.0% | -45.7M+77.7% | -205M+28.4% | -287M+55.0% | -637M-587.1% | |
| Interest expense | 0.00 | 0.00-100.0% | 7.00K-99.5% | 1.33M-58.3% | 3.19M-91.1% | |
| Pre-tax income | -85.5M-98.9% | -43.0M+79.8% | -213M | — | — | |
| Income tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -85.5M-98.9% | -43.0M+79.8% | -213M+37.2% | -340M+42.2% | -588M-330.9% | ||
| Discontinued operations | 0.00-100.0% | 3.26M+201.4% | -3.21M+96.2% | -85.0M | — | |
| Net income to common | — | — | -213M+37.2% | -340M+42.2% | -588M-330.9% | |
| — | — | -$0.44+38.0% | -$0.71+50.0% | -$1.42+7.8% | ||
| EPS (basic) | — | — | -$0.44+38.0% | -$0.71+50.0% | -$1.42+7.8% | |
| Weighted-avg shares (basic) | 512M+4.5% | 490M+1.6% | 482M+1.2% | 476M+15.3% | 413M+365.6% | |
| Weighted-avg shares (diluted) | 512M+4.5% | 490M+1.6% | 482M+1.2% | 476M+15.3% | 413M+365.6% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 308M-10.3% | 343M-19.8% | 428M-31.5% | 625M-16.9% | 753M+296.5% | ||
| Cash & equivalents | 78.3M-59.8% | 195M+58.3% | 123M+18.4% | 104M-65.4% | 300M+224.8% | |
| Prepaid expenses | 18.2M+38.2% | 13.2M-8.6% | 14.4M-20.5% | 18.1M+23.5% | 14.7M+4803.1% | |
| Other current assets | 10.6M-31.8% | 15.6M-16.2% | 18.6M+360.4% | 4.04M+60.1% | 2.52M+744.5% | |
| 541M-6.8% | 581M+1.8% | 571M-29.4% | 809M-15.0% | 951M+255.8% | ||
| Property, plant & equipment | 6.38M+20.3% | 5.31M+4.4% | 5.08M-11.7% | 5.75M+151.6% | 2.29M+10.1% | |
| Operating lease right-of-use | — | — | 3.38M-16.0% | 4.03M-25.0% | 5.37M-31.9% | |
| Goodwill | — | — | 0.00-100.0% | 11.7M+845.2% | 1.24M+3.6% | |
| Other non-current assets | 24.1M+81.9% | 13.3M-2.7% | 13.6M-13.4% | 15.7M+50.8% | 10.4M+17.4% | |
| 209M-2.2% | 214M-18.2% | 261M-39.5% | 432M+16.0% | 372M+126.5% | ||
| Accrued liabilities | 36.2M+4.8% | 34.6M-7.0% | 37.2M+14.6% | 32.4M+15.3% | 28.1M+470.0% | |
| Deferred revenue | — | — | 3.10M | 0.00 | 0.00 | |
| Short-term & current debt | — | — | — | — | 0.00-100.0% | |
| Current lease liability | — | — | 1.67M-8.9% | 1.83M-40.3% | 3.06M-36.2% | |
| Other current liabilities | 3.32M-4.1% | 3.47M-40.0% | 5.78M+1089.5% | 486K+565.8% | 73.0K+1360.0% | |
| 232M-3.0% | 240M-15.7% | 284M-37.1% | 452M+10.0% | 411M-5.1% | ||
| Long-term debt | — | — | — | 0.00-100.0% | 19.9M-81.3% | |
| Non-current lease liability | — | — | 3.00M-25.7% | 4.03M-16.5% | 4.83M-23.9% | |
| Operating lease liability (total) | 3.30M-0.9% | 3.33M-28.7% | 4.66M-20.4% | 5.86M-25.7% | 7.89M | |
| Other non-current liabilities | 23.5M-10.0% | 26.1M+12.6% | 23.2M+43.0% | 16.2M+14.9% | 14.1M+7.5% | |
| 309M-9.5% | 341M+19.1% | 286M-19.8% | 357M-33.3% | 535M+186.8% | ||
| Additional paid-in capital | 2.68B+4.1% | 2.58B+4.7% | 2.46B+6.1% | 2.32B+7.7% | 2.15B+423.0% | |
| Retained earnings | -2.29B-3.9% | -2.20B-2.0% | -2.16B-11.0% | -1.95B-20.4% | -1.62B-57.0% | |
| Treasury stock | 86.2M+178.1% | 31.0M+143.5% | 12.7M+95.6% | 6.51M+4327.9% | 147K | |
| Accumulated other comprehensive income | 528K+133.3% | -1.58M+33.2% | -2.37M+74.7% | -9.37M-384.7% | -1.93M-19440.0% | |
| Non-controlling interest | — | — | — | 0.00-100.0% | 3.90M+0.0% | |
| Total equity incl. non-controlling | 309M-9.5% | 341M+19.1% | 286M-19.8% | 357M-33.9% | 540M+188.1% | |
| Total liabilities & equity | 541M-6.8% | 581M+1.8% | 571M-29.4% | 809M-15.0% | 951M+255.8% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -66.9M-292.1% | 34.8M+124.1% | -145M+29.1% | -204M+27.8% | -282M-138.3% | ||
| Depreciation & amortization | -1.84M+27.0% | -2.52M+37.1% | -4.01M-167.1% | -1.50M-851.5% | 200K+202.6% | |
| Intangible amortization | — | — | — | 100K-85.7% | 700K | |
| Share-based compensation | 104M-9.3% | 114M-18.9% | 141M-14.2% | 164M+0.4% | 164M+2213.1% | |
| Deferred income taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | |
| Change in receivables | 43.3M+443.2% | -12.6M-95.9% | -6.44M-128.6% | 22.6M+142.7% | 9.30M-28.1% | |
| 4.08M+621.4% | 565K-99.6% | 140M+47.2% | 95.1M+121.8% | -435M-416.9% | ||
| Capital expenditure | 2.04M+31.3% | 1.56M+166.4% | 584K-86.9% | 4.47M+517.8% | 723K+4.3% | |
| Free cash flow | -69.0M-307.2% | 33.3M+122.9% | -145M+30.3% | -208M+26.4% | -283M-137.5% | |
| Acquisitions | 0.00 | 0.00 | 0.00-100.0% | 16.2M | 0.00 | |
| Purchases of investments | 205M+1.9% | 201M+14.6% | 176M-52.5% | 369M-57.8% | 876M+402.7% | |
| -53.4M-207.5% | -17.4M-242.4% | -5.07M-2.2% | -4.96M-100.5% | 925M+15734.9% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 1.10M+467.9% | 193K-82.7% | 1.12M | 0.00-100.0% | 284M | |
| Common stock repurchased | 18.3M+932.6% | 1.77M | 0.00 | 0.00-100.0% | 147K | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net change in cash | -116M-744.0% | 18.0M+285.7% | -9.72M+91.5% | -114M-154.8% | 208M+738.9% | |
| Interest paid | — | — | 0.00 | 0.00-100.0% | 1.68M-63.4% | |
| Income taxes paid | 0.00 | — | — | — | — | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 1.22B-22.0% | 1.56B+240.4% | 458M+3.0% | 444M-71.6% | 1.56B+4.9% | |
| P/S | 0.6×-44.4% | 1.1× | — | 0.1×-86.1% | 1.1×-52.1% | |
| P/B | 3.9×-13.8% | 4.6×+221.1% | 1.4×+25.5% | 1.1×-61.2% | 2.9× | |
| P/FCF | — | 46.8× | — | — | — | |
| FCF yield | — | 2.1% | — | — | — | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: CLOV’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all CLOV filings on SEC EDGAR → Not investment advice.